1,092
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Urinary excretion of the acrylonitrile metabolite 2-cyanoethylmercapturic acid is correlated with a variety of biomarkers of tobacco smoke exposure and consumption

, , , &
Pages 89-96 | Received 19 Aug 2010, Accepted 16 Oct 2010, Published online: 25 Nov 2010

Reference

  • Altman DG. (1991). Practical statistics for medical research. London, Chapman and Hall.
  • Bergmark E. (1997). Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem. Res. Toxicol. 10, 78–84.
  • Bramer SL and Kallungal BA. (2003). Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers 8, 187–203.
  • Burns DM, Dybing E, Gray N, Hecht S, Anderson C, Sanner T, O’Connor R, Djordjevic M, Dresler C, Hainaut P, Jarvis M, Opperhuizen A, and Straif K. (2008). Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob. Control 17, 132–141.
  • Dong JZ, Glass JN, and Moldoveanu SC. (2000). A Simple GC-MS Technique for the Analysis of Vapour Phase Mainstream Cigarette Smoke. J. Microcolumn Separations 12, 142–152.
  • FDA. Food and Drug Administration (FDA) (2001): Guidance for Industry - Bioanalytical Method Validation 1–22.
  • Fennell TR, Kedderis GL, and Sumner SC. (1991). Urinary metabolites of [1,2,3-13C]acrylonitrile in rats and mice detected by 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 4, 678–687.
  • Fennell TR, MacNeela JP, Morris RW, Watson M, Thompson CL, and Bell DA. (2000). Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione S-transferase T1-null and M1-null genotypes. Cancer Epidemiol. Biomarkers Prev. 9, 705–712.
  • IARC. International, Agency for Research on Cancer (1979). Acrylonitrile, acrylic and modacrylic fibres, and acrylonitrile-butadiene-styrene and styrene-acrylonitrile copolymers. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 19, 73–113.
  • IARC. International, Agency for Research on Cancer (1999). Acrylonitrile. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 71, 43–108.
  • IARC. International, Agency for Research on Cancer (2004). Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 83, 1–1438.
  • International Conference on Harmonization (1996). Harmonized tripartite guidelines for good clinical practice. Directive 91/507/EEC. The rules governing medicinal products in the European Community.
  • International Organization for Standardization (2000). ISO Standard 3308, in Routine Analytical Cigarette-smoking Machine-definitions and standard conditions. 4.
  • IOM (2001). Institute of Medicine. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction.
  • Jakubowski M, Linhart I, Pielas G, and Kopecky J. (1987). 2-Cyanoethylmercapturic acid (CEMA) in the urine as a possible indicator of exposure to acrylonitrile. Br. J. Ind. Med. 44, 834–840.
  • Jenkins RA, Guerin MR, Tomkins BA. (2000). The chemistry of environmental tobacco smoke: composition and measurement. 2nd ed. Boca Raton: Lewis Publishers.
  • Lambotte-Vandepaer M, Duverger-van BM, and Rollmann B. (1985). Metabolism and mutagenicity of acrylonitrile: an in vivo study. Environ. Mutagen. 7, 655–662.
  • Leonard A, Gerber GB, Stecca C, Rueff J, Borba H, Farmer PB, Sram RJ, Czeizel AE, and Kalina I. (1999). Mutagenicity, carcinogenicity, and teratogenicity of acrylonitrile. Mutat. Res. 436, 263–283.
  • Massachusetts General Law (1997) Ch. 94Sect. 307B, 105 Code of Massachusetts Regulation 660.000.
  • Miller SL, Branoff S, and Nazaroff WW. (1998). Exposure to toxic air contaminants in environmental tobacco smoke: an assessment for California based on personal monitoring data. J. Expo. Anal. Environ. Epidemiol. 8, 287–311.
  • Scherer G, Engl J, Urban M, Gilch G, Janket D, and Riedel K. (2007). Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul. Toxicol. Pharmacol. 47, 171–183.
  • Scherer G, Urban M, Hagedorna H-W, Serafin R, Feng S, Kapurb S, Muhammad R, Jin Y, Sarkarb M, Roethig H-J. (2010). Determination of methyl-, 2-hydroxyethyl- and 2-cyanoethylmercapturic acids as biomarkers of exposure to alkylating agents in cigarette smoke. J. Chromatography B. 878, 2520–2528.
  • Schettgen T, Broding HC, Angerer J, and Drexler H. (2002). Hemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile and acrylamide-biomarkers in occupational and environmental medicine. Toxicol. Lett. 134, 65–70.
  • Schettgen T, Musiol A, Alt A, Ochsmann E, and Kraus T. (2009). A method for the quantification of biomarkers of exposure to acrylonitrile and 1,3-butadiene in human urine by column-switching liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 393, 969–981.
  • Shepperd CJ, St Charles FK, Lien M, and Dixon M. (2006) Validation of Methods for Determining Consumer Smoked Cigarette Yields from Cigarette Filter Analysis. Beitrage zur Tabakforschung International 22, 176–184.
  • Shepperd CJ, Eldridge AC, Mariner DC, McEwan M, Errington G, and Dixon M. (2009). A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure. Regul. Toxicol. Pharmacol. 55, 97–109.
  • St Charles FK, Krautter GR, Dixon M, and Mariner DC. (2006). A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites. Psychopharmacology (Berl) 189, 345–354.
  • Sumner SC, Selvaraj L, Nauhaus SK, and Fennell TR. (1997). Urinary metabolites from F344 rats and B6C3F1 mice coadministered acrylamide and acrylonitrile for 1 or 5 days. Chem. Res. Toxicol. 10, 1152–1160.
  • Thier R, Lewalter J, and Bolt HM. (2000). Species differences in acrylonitrile metabolism and toxicity between experimental animals and humans based on observations in human accidental poisonings. Arch. Toxicol. 74, 184–189.
  • World Medical Association. Declaration of Helsinki - Recommendations guiding physicians in biomedical research involving human subjects. Adopted 1964, amended 1975, 1983, 1989, 1996, 2000, 2002, and 2004.
  • Xu X, Iba MM, and Weisel CP. (2004). Simultaneous and sensitive measurement of anabasine, nicotine, and nicotine metabolites in human urine by liquid chromatography-tandem mass spectrometry. Clin. Chem. 50, 2323–2330.